GRFS Grifols, S.A.
7.500USD-0.27%Mkt Cap: 5.10B $P/E: 9.741d ago
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates thr…
Industry Peers
Drug Manufacturers - General$1.06TUSDP/E 39.9
LLY
Eli Lilly and Company$1.01TUSDP/E 39.6
$622.84BUSDP/E 29.9
$479.52BUSDP/E 76.7
ABBV
AbbVie Inc.$458.43BUSDP/E 76.9
$335.37BUSDP/E 24.1
$352.29BUSDP/E 113.3
ROP
Roche Holding AG$327.37BUSDP/E 23.5
MRK
Merck & Co., Inc.$351.41BUSDP/E 112.9
ROG
Roche Holding AG$331.80BUSDP/E 21.4
$260.36BUSDP/E 22.9
$272.33BUSDP/E 21.6
$260.71BUSDP/E 25.2
NVS
Novartis AG$266.84BUSDP/E 22.5
$238.84BUSDP/E 25.7
$248.33BUSDP/E 23.9
$223.32BUSDP/E 25.7
$205.33BUSDP/E 24.4
AMGN
Amgen Inc.$217.60BUSDP/E 25.6
$182.09BUSD
Key Statistics
Company
Market Cap5.10B USD
Enterprise Value21.49B USD
Revenue (TTM)7.42B USD
Gross Profit2.86B USD
Net Income (TTM)402.00M USD
Revenue/Share5.42 USD
Last Price7.500 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees25.3K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)9.74
P/E (Forward)5.21
PEG0.19
EV/EBITDA13.06
EV/Revenue2.90
P/S0.69
P/B1.64
EPS (TTM)0.77
EPS (Forward)1.44
52W Range
6.96017% of range10.23
52W High10.23 USD
52W Low6.960 USD
Profitability
Gross Margin38.00%
Oper. Margin15.90%
EBITDA Margin22.17%
Profit Margin5.34%
ROE7.63%
ROA2.04%
Growth
Revenue Growth-0.90%
Earnings Growth32.90%
Cash Flow & Leverage
Operating CF1.05B USD
CapEx (TTM)423.00M USD
FCF Margin7.72%
FCF Yield11.22%
Net Debt8.82B USD
Net Debt/EBITDA5.36
Balance Sheet
Debt/Equity1.81
Current Ratio2.37
Quick Ratio0.70
Book Value/Sh4.59 USD
Cash/Share0.40 USD
Dividends
Fwd Div Rate0.11 USD
Trail. Div Rate0.00 USD
Div. Yield1.40%
5Y Avg Yield2.14%
Payout Ratio37.97%
Ex-Div DateJul 2, 2026
Pay DateJul 9, 2026
Splits
Last Split2:1
Split DateJan 4, 2016
Analyst Consensus
Rating—
Target (Mean)10.87 USD
Upside (mean)+44.9%
Target Range10.00 USD – 11.73 USD
10.00+44.9% to mean11.73
# Analysts2
Ownership
Shares Out.258.22M
Float836.45M
Insiders0.00%
Institutions57.09%
Short Interest
Short Ratio8.4d
Short % Out.0.50%
Shares Short3.41M
Short (prev mo.)3.52M
Technical
SMA 507.711 (-2.7%)
SMA 2008.138 (-7.8%)
Beta1.20
S&P 52W Chg16.45%
Avg Vol (30d)550.70K
Avg Vol (10d)879.59K
Technical Indicators
RSI (14)50.0
MACD-0.0803
MACD Signal-0.1078
MACD Hist.+0.0275
BB Upper7.763 USD
BB Middle7.428 USD
BB Lower7.093 USD
BB Width9.01%
ATR (14)0.1581 USD
Vol Ratio (20d)0.41x